WELCOME TO #ESHLYMPHOID2021

October 14, 2021

6th ESH Translational Research Conference
LYMPHOID MALIGNANCIES

October 14-17, 2021 - E-Conference
FREE REGISTRATION

Click here to see the Full programme

Highlights of Day 1

15:30-15:40 Welcome
Michael Hallek (Cologne), Georg Lenz (Münster), Laurie Sehn (Vancouver), Louis Staudt (Bethesda)

15:40-17:45 Session I: B-cell development and lymphomagenesis
Chairs: Ralf Küppers (Essen) & Laura Pasqualucci (New York)
Interactive Live Panel Discussion at 17:12

17:55-20:00 Session II: Genetics of malignant lymphomas and clonal evolution
Chairs: Margaret Shipp (Boston) & Louis Staudt (Bethesda)
Interactive Live Panel Discussion at 19:27

Highlights of Day 2

12:50-13:50  Simultaneous Meet the Expert sessions (Clinical & Non-clinical)
- CLL and indolent lymphoma
José Ignacio Martin-Subero (Barcelona) & John Seymour (Melbourne)
- Pathogenesis and kinase inhibitors in lymphoma
Georg Lenz (Münster) & Louis Staudt (Bethesda)

14:00-16:00  Session III: Epigenetics in malignant lymphomas
Chairs: Ari Melnick (New York) & Franck Morschhauser (Lille)
Interactive Live Panel Discussion at 15:32

16:00-17:50  Session IV: Deregulated proteome and metabolome
Chairs: Kojo Elenitoba (Philadelphia) & Thomas Oellerich (Frankfurt)
Interactive Live Panel Discussion at 17:22

17:50-19:50  Session V: Single cell analyses, circulating tumor DNA, MRD
Chairs: Dan Landau (New York) & Bertrand Nadel (Marseille)
Interactive Live Panel Discussion at 19:22

Highlights of Day 3

13:20-14:20 Mentored Poster Walk
Poster Leader: Barbara Eichhorst (Cologne)

15:35-17:30 Session VI: Oncogenic signaling pathways
Chairs: Georg Lenz (Münster) & Adrian Wiestner (Bethesda)
Interactive Live Panel Discussion at 17:07

18:45-19:45 Simultaneous Meet the Expert sessions (Clinical & Non-clinical)
- Biology and genomics and clonal evolution of lymphoma
Elias Campo (Barcelona) & David Kurtz (Stanford)
- DLBCL and MCL
Laurie Sehn (Vancouver) & Frederick Locke (Tampa)

20:30-22:35 Session VII: Utilizing oncogenic signaling therapeutically
Chair: Laurie Sehn (Vancouver) & John Seymour (Melbourne)
Interactive Live Discussion at 22:02

Highlights of Day 4

15:05-17:50 Session VIII: Immunologic approaches in the treatment of lymphomas
Chairs: Ranjana Advani (Stanford) & Pier Luigi Zinzani (Bologna)
Interactive Live Panel Discussion at 17:17

17:50-18:00 Closing remarks

WELCOME MESSAGE FROM THE E-CONFERENCE CHAIRPERSONS

Already registered ?

SCIENTIFIC TOPICS:

– B-cell development and lymphomagenesis
– Genetics of malignant lymphomas and clonal evolution
– Epigenetics in malignant lymphomas
– Deregulated proteome and metabolome
– Single cell analyses, circulating tumor DNA, MRD
– Oncogenic signaling pathways
– Utilizing oncogenic signaling therapeutically
– Immunologic approaches in the treatment of lymphomas

TIMING OF THE SCIENTIFIC PROGRAMME:

Participants will be joining us from all over the world and from different time zones.To make sure that everyone has access to the full scientific programme at a convenient hour,registration will allow participants to join boththe LIVE PROGRAMME (October 14-17, 2021) andthe PROGRAMME ON-DEMAND (October 4 - November 17, 2021).

TO ACCESS THE FINAL PROGRAMME CLICK HERE

The “Live Programme” will be streamed live CEST time.
It will include Meet the Expert sessions, interactive panel discussions, Q&A periods and Mentored Poster Walks. It will also include some pre-recorded lectures that will be streamed live, followed by their corresponding fully live Q&A period.

The “Programme on-demand” is now available.
It will initially include the pre-recorded components of the scientific programme. It will be progressively enriched by the meeting’s live, interactive components which will be recorded real time during the meeting.

E-POSTERS: October 4 - November 17, 2021
The Poster Hall will also remain open until November 17, 2021.
The Mentored Poster Walks scheduled in the LIVE PROGRAMME will also become available in the PROGRAMME ON-DEMAND.

VIRTUAL EXHIBITION: October 4 - November 17, 2021
We invite you to visit the Exhibition area as of October 4.
Our corporate partners will be pleased to welcome & chat with you.

Learning objectives:

Improved understanding of :
– current developments in the field of molecular pathogenesis of indolent and aggressive B-cell lymphoma including CLL
– current developments in the field of the molecular pathogenesis of T-cell lymphoma
– prognostic and predictive markers and their impact in specific clinical situations
– current treatments and future therapeutic perspectives.

MORE INFORMATION

With the support of*: